† Study has passed its completion date and status has not been verified in more than two years.
A Phase II Multi-centre, Extension Study to Investigate the Long Term Safety of ONO-2506PO in Patients Diagnosed With Amyotrophic Lateral Sclerosis (ALS)
Controlled Study of ONO-2506PO in Patients With Parkinson's Disease in Japan
Placebo Controlled Study of ONO2506PO in the Presence of Riluzole in Patients With Amyotrophic Lateral Sclerosis (ALS)
Study of ONO-2506 in Patients With Acute Ischemic Stroke
Effects of ONO-2506PO in Patients With Alzheimer's Disease
A Study to Evaluate the Effects of ONO-2506 Intravenous Infusion in Patients With Acute Ischemic Stroke